This is the first in a series of chapters that demonstrate application of RMM to modeling systematic variation (Chapters 14 18). In this chapter we address data-sets that have appeared in the ...
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) is preparing to trial new timelines for variation applications to “provide greater clarity and more effective monitoring.” NPRA published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results